A First-Line Treatment Option for Your Patients With Advanced Renal Cell Carcinoma

Program Details

Attend a virtual presentation on:

A First-Line Treatment Approach for Your Adult Patients With Advanced Renal Cell Carcinoma

Review the efficacy and safety profile of a first-line treatment option for adult patients with advanced renal cell carcinoma (RCC)
Discuss monitoring and management of adverse reactions associated with this treatment option
Discuss how this treatment option may fit into your treatment strategy for appropriate patients with aRCC

Speaker Program Information

A meal may be offered. Alcohol will not be provided.

Eisai complies with all relevant laws, regulations, and codes of conduct. In some jurisdictions, meals may be prohibited (e.g., VT, U.S. Dept. of Veterans Affairs & Defense), capped (MN, NJ) or reportable (CT, DC, MA, NV, OR). If you are a licensed healthcare professional in MN, NJ or VT, employed by U.S. Dept. of Veterans Affairs or Defense or other jurisdiction that may prohibit or cap meals, please identify yourself to an Eisai representative.